Zuraiz Chaudhary - 08 Oct 2025 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Role: Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer.
Signature: /s/ Zuraiz Chaudhary
Issuer symbol: TTRX
Transactions as of: 08 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 10 Oct 2025, 09:42:11 UTC
Previous filing: 07 Oct 2025
Next filing: 23 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chaudhary Zuraiz	Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer.	C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE	/s/ Zuraiz Chaudhary	10 Oct 2025	0002086494

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TTRX	Employee stock option (right to buy)	Award	$0	+240,000		$0.000000	240,000	08 Oct 2025	Common Stock	240,000	$10.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects an award of stock options to purchase shares of the Issuer's common stock granted under the Company's 2025 Omnibus Incentive Plan. 25% of the options shall vest on May 1, 2026, and 6.25% of the options shall vest in equal quarterly installments thereafter, in each case, subject to the reporting person's continued employment through the applicable vesting date.

Remarks:

Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer.